DelveInsight Business Research, LLP: Congenital Hyperinsulinism Market to Expand at a CAGR of 12% During the Forecast Period (2026-2036) as Rising Disease Recognition and Novel Therapies Fuel Market Growth
Kort samengevat
The congenital hyperinsulinism market is poised for steady growth, driven by increasing disease awareness, improved neonatal screening, and advances in genetic and molecular diagnostics. Growth
Verder lezen bij de bron
Bekijk het volledige nieuwsbericht rechtstreeks bij FinanzNachrichten.de.
Lees het volledige bericht ↗